|NeoGenomics announces launch of new NeoLAB assays to diagnose ...|
It is estimated that more than 600,000 bone marrow biopsies are performed annually in the U.S. to diagnose and monitor patients with various hematologic cancers. However, bone marrow biopsies are a painful and uncomfortable procedure for patients, and ...
News-Medical.net - Thu, 11 Jun 2015 06:00
|NeoGenomics Launches Twelve NeoLAB™ "Liquid Biopsy" Tests for ...|
PharmiWeb.com (press release) - Thu, 11 Jun 2015 04:03
|Immunotherapy in Hematologic Malignancies|
Immune checkpoint inhibitors targeted against CTLA-4 and PD-1 have demonstrated promising efficacy across solid tumors and hematological malignancies, with FDA approvals for the treatment of metastatic melanoma and advanced lung cancer.
OncLive - Wed, 24 Jun 2015 16:26
|NeoGenomics Launches Twelve NeoLAB™ 'Liquid Biopsy' Tests For ...|
Giles FJ, Albitar M. Plasma-based testing as a new paradigm for clinical testing in hematologic diseases. Expert Review of Molecular Diagnostics. 2007 Sep;7(5):615-23. Jilani I, Estey E, Manshuri T, Caligiuri M, Keating M, Giles F, Thomas D, Kantarjian ...
Laboratory Network - Fri, 12 Jun 2015 02:56
|Higher Graft CD8 Dose Predicts Better Survival in Hematologic Malignancies|
Higher graft CD8 dose predicted better survival in patients undergoing reduced-intensity conditioned (RIC) allogenic hematopoietic stem-cell transplantation (alloHSCT) in adults with hematologic malignancies, a new study published online ahead of print ...
Cancer Therapy Advisor - Wed, 10 Jun 2015 08:14
|Karyopharm Presents Hematologic Cancer Data on Lead Drug Candidate ...|
Over 900 patients have been treated with selinexor in company- and investigator-sponsored Phase 1 and Phase 2 clinical trials in advanced hematologic malignancies and solid tumors. Karyopharm has initiated four registration-directed clinical trials of ...
Nasdaq - Mon, 22 Jun 2015 03:52
|Multimodality therapy approaches, local and systemic treatment, compared with ...|
Hematologic and non-hematologic toxicities were graded according to Common Terminology Criteria for Adverse Events 4.0. Twenty-one ... The two groups were balanced in terms of patients characteristics and disease status as detailed in Table 2 ...
BMC Blogs Network - Mon, 29 Jun 2015 03:18
|Increased risk of nephrolithiasis is associated with treatment of hematologic ...|
The incidence of nephrolithiasis in a population of patients (over 1 300 patients with up to 10 years follow-up) with lymphoproliferative and myeloproliferative disorders was 5.5%. In multivariate analysis, we report that diabetes mellitus ...
UroToday - Tue, 16 Jun 2015 11:11
|Agreement on the prescription of antimicrobial drugs|
Organ dysfunctions were diagnosed based on the following measurements: cardiovascular dysfunction: systolic BP <90 mmHg or mean BP <65 mm Hg or use of vasopressors (noradrenaline, dopamine, epinephrine, vasopressin); hematologic disorders: ...
BMC Blogs Network - Mon, 29 Jun 2015 02:11